Contact us
Expertise in real world data
Benefit-risk analysis for regulators
We provide a comprehensive service not widely available among CROs or consultancies for conducting quantitative benefit risk analysis between products.
Quantitative benefit-risk assessment requires all of the following ingredients:
EMA methods for product approval & new PSUR
Copyright © 2013 Oxon All Rights Reserved - Late phase CRO